Overview

Gender

male

Investor Type

Angel

Investor Stage

Seed

Mr. Clapper is presently the Chief Executive Officer of Minerva Surgical, Inc., a medical device start-up company based in the Silicon Valley; Cupertino, CA. Mr. Clapper also serves as a member of the board of directors at Silicon Valley Bank, NeoMend, Baxano, and Dfine. Mr. Clapper holds a B.S. in Marketing from Bowling Green State University.

Mr. Clapper began his medical device career at Johnson and Johnson. During 16 years at J&J, he held positions from Sales Representative to Vice President of Sales and Marketing, and Member of the Board of Directors of Ethicon Endo-Surgery. In 1993, he became the President and CEO of Focal, a biomaterials company in Boston. Focal completed its Lehman Brothers/Piper Jaffray lead IPO in December 1997. In 1999, Mr. Clapper began serving as President and CEO of Novacept in Palo Alto, CA until the acquisition in 2004 by Cytyc Corporation for $325 million. Novacept manufactured and marketed the Novasure System. In 2005, he became the President and CEO of SurgRx, a surgical sealing and cutting device company in Redwood City, CA. In August of 2008, SurgRx signed a definitive agreement to be acquired by Ethicon Endo-Surgery, a Johnson and Johnson company.

Until their acquisitions, Mr. Clapper held board positions at St. Francis Medical Technologies and Conor MedSystems. Companies at which Mr. Clapper has served, either as CEO or board member, have been acquired over the last four years for a cumulative value of $2.73 billion.